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Introduction: Primitive neuroectodermal tumors (PNET) form a group of tumors defined by their appearance that
are thought to develop from primitive (undifferentiated) nerve cells in the brain. They are rare tumors and their
incidence is not well defined.
Case presentation: An 18-month-old male presenting with typical Cushingoid appearance (moon face, central
obesity, hirsutism and growth arrest) was admitted for evaluation of endocrine problems. Subsequent laboratory
studies revealed markedly elevated adrenocorticotropic (ACTH) and cortisol levels, as well as a hypokalemic
metabolic alkalosis, these data are consistent with the diagnosis of Cushing's disease. He was treated with
metyrapone to control hypercortisolemia. One month and a half later, a mass was detected in the abdomen by
ultrasonography. An abdominal Computed tomography confirmed a large heterogeneous retroperitoneal mass
with a significant amount of extension into surrounding structures which was removed by laparoscopic ab-
dominal surgery. The patient's symptoms completely resolved and the ACTH and cortisol levels were also greatly
reduced. Histologically, the tumor tissue consistent with the diagnosis of the retroperitoneal primitive neu-
roectodermal tumor which was confirmed immunohistochemically. This case demonstrates the successful di-
agnosis and treatment of a rare neoplasm.
Conclusion: This is the first rare case with ectopic ACTH syndrome caused by the peripheral primitive neu-
roectodermal tumor.
1. Introduction
Peripheral primitive neuroectodermal tumor (PNET) is an un-
common tumor and the overall incidence is 1% of all sarcomas [1].
Primitive neuroectodermal tumors (PNETs) are rare small round cell
neoplasms, first described in 1918 by Stout [2] as a malignant tumor
arising from major nerve [3]. This tumor can occur at any age, although
the peak age incidence is during adolescence and young adulthood and
the tumors are rarely observed in children< 3 years old. The incidence
of peripheral PNET in the abdomen and pelvis, including the retro-
peritoneum, is about 14% of all peripheral PNETs [4]. Cushing's syn-
drome is a disorder of hypercortisolism which has a characteristic ap-
pearance (moon facies, buffalo hump, truncal obesity, and purple
striae). Furthermore, it is associated with a variety of organ dysfunc-
tions including cardiovascular, endocrine, neural, gastrointestinal, skin,
and musculoskeletal. Ectopic secretion of ACTH accounts for ∼10% of
Cushing's syndrome etiologies [5–8].The following case is that of an 18
months-old Iranian boy presenting with Cushing's syndrome due to
ACTH-secreting peripheral PNET. Our case is very rare in its pre-
sentation.
2. Case presentation
In september2017, an 18-month-old male admitted in endocrine
department with symptoms of moon face, general weakness, central
obesity, growth arrest and short stature of 5 months duration. On
physical exam, the patient was noted to have 1 + pitting edema on his
lower extremities bilaterally and hirsutism in back of trunk. At the time
of presentation, he did not appear severely cushingoid appearance and
his blood pressure was (115/61 mm Hg). Laboratory results revealed
highly elevated ACTH and cortisol levels (ACTH = 731 pg/mL; AM
cortisol = 142.8 μg/dL; 24-h urine cortisol 12743.5μg/24 hours total
volume). In addition, the patient was also hypokalemic (3.0 mEq/L)
and had a metabolic alkalosis (pH = 7.89, HCO3 = 41 mEq/L).
Dexamethasone suppression test was considered: however, in the pre-
sence of very high ACTH and cortisol levels, hypokalemia, and
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metabolic alkalosis, as well as clinical findings, a primary pituitary
tumor or an ectopic ACTH syndrome was suspected. Brain MRI was
negative for primary pituitary tumor. Abdominal ultrasonography
(USG) showed a solid, calcified heterogeneous mass measuring
57 × 46 × 36 mm in front of anteromedial of right kidney near to
inferior pole. A Doppler ultrasound test showed the blood flow through
inferior vena cava (IVC) restricted by pressure effect of tumor. Contrast-
enhanced computed tomography abdomen showed large lobulated,
necrotic and calcified hypodense enhancing mass measuring
47.6 × 44.3 mm in the largest diameters that extending from anterior
of right kidney to retroperitoneum and involving retroperitoneal space.
The lesion was abutting the IVC, displacing it laterally (Fig. 1) The
USG/CT appearance of the mass, in combination with the clinical and
laboratory findings, was suspicious for neuroblastoma or pPNET. In-
formed consent was obtained from parents prior to surgery. Total re-
section of mass was performed by laparoscopic abdominal surgery.
After surgery, his metabolic abnormalities were controlled. Grossly, the
tumor was brownish, soft and multilobulated. Gross examination of the
specimen sent to us revealed a soft tissue mass measuring about
47×42×37 mm, cut surface of which revealed an encapsulated
creamy to brownish mass with lobulated and variegated appearance
with solid and necrotic areas with foci of calcification (Fig. 2). On
microscopic examination, there were lobules of tumor cells separated
by fibrous septa. The tumor cells comprised of small cells with round
vesicular nuclei, inconspicuous nucleoli, scanty eosinophilic cytoplasm
with frequent homer wright rosettes and pseudorosettes (Fig. 3). The
immunohistochemical evaluation revealed a diffuse CD99 and vimentin
positivity in the cytoplasm of the neoplastic cells. Pan keratin, cyto-
keratin AE1/AE3, myogenin and CD45 were negative. The S-100 pro-
tein was weakly positive in tumor cells. Ki67 immunostain shows about
65% immunoreactivity. Also, there were focal expression of synapto-
physin and ACTH (Fig. 3). These findings represent an ACTH-secreting
PNET. Following the operation, his ACTH level decreased to 22 pg/mL.
Ki67 immunostain shows about 65% immunoreactivity. He was dis-
charged on hydrocortisone 5 mg in the morning and 5mg in the evening
for secondary glucocorticoid deficiency because of prolonged ectopic
ACTH secretion. When the patient finished the hydrocortisone course,
he maintained a normal ACTH, morning plasma cortisol, and urine
cortisol levels. Furthermore, his Cushing's syndrome symptoms com-
pletely resolved.
3. Discussion
Approximately 5%–10% of cases of Cushing syndrome (hy-
percortisolism) are paraneoplastic.[9] Paraneoplastic Cushing's syn-
drome has been attributed to ectopic adrenocorticotropin (ACTH)
secretion, which may result in several types of tumors, including car-
cinoid and pancreatic neuroendocrine tumors [10], small cell lung
cancer and thyroid medullary carcinoma [11], Wilms tumor [12],
prostatic cancer [13,14], neuroblastoma [11], and thymus tumor
[15,16]. Patients often present with symptoms of paraneoplastic
Cushing syndrome before a cancer diagnosis is made. Similarly, relapse
of paraneoplastic Cushing syndrome may herald tumor recurrence
[12].Paraneoplastic Cushing syndrome arises from tumor secretion of
adrenocorticotropic hormone or corticotropin-releasing factor [9,13].
The diagnosis of ectopic ACTH syndrome secondary to esthesioneuro-
blastoma was established based on the presence of ACTH seen on im-
munohistochemical staining of the tumor, the disappearance of symp-
toms, as well as a decrease and normalization of plasma ACTH and
cortisol levels after resection of the tumor. Peripheral primitive neu-
roectodermal tumor (pPNET) is a group of malignant small round cell
tumor with neural crest origin that arises outside the central and
sympathetic nervous system [17].They belong to the Ewing sarcoma
Fig. 1. Contrast enhanced computed tomography abdomen showed large lobulated necrotic hypodense enhancing lesion involving part of retroperitoneal space.
Fig. 2. Gross image of a renal primitive neuroectodermal tumor. This specimen
is notable for a variegated appearance. Select areas of the tumor feature a tan/
brown or dark brown/red coloration, whereas other sections of the tumor
feature a more yellow appearance, helping to illustrate the range of coloration
observable on gross examination. This specimen is also notable for its lobulated
appearance.
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family of tumors with similar histologic and immunohistochemical
characteristics [18]. Peripheral PNETs are rare in the abdomen [17].
This tumor rarely presents as an organ-derived neoplasm [19]. Care-
fully the selected immunohistochemical panel is important for differ-
entiating this tumor from other small round cell tumors in abdomens
such as rhabdomyosarcoma, neuroblastoma, clear cell sarcoma of the
kidney, non-Hodgkin lymphoma and Ewing's sarcoma. Im-
munohistochemically, PNET cells express vimentin, NSE, and CD99
[20]. The positive reactivity to CD99 is a clue for PNET diagnosis [19].
Review of radiologic findings showed that most cases of retroperitoneal
PNETs in the literature, similar to our case, presented as a large mass
with areas of necrosis and heterogeneous enhancement in contrast
imaging. Some cases had areas of hemorrhage, but in our case, there
was no hemorrhage. Our case had several foci of curvilinear calcifica-
tion compared to other case reports, in which calcification was a rare
finding (one of ten cases in a case series) [21]. Organ invasion and
displacement, such as direct invasion or displacement of the pancreas,
kidney, spleen, and stomach was present in some cases, including our
case but our case didn't show [21].There was no clinical or imaging
evidence of venous thrombosis in the inferior vena cava (IVC), while
venous thrombosis has been detected in other patients [20,21]. Ap-
proximately 20% of the patients present with metastatic disease; out of
which 44% present with lung metastases only, 51% have bone or bone
marrow involvement (with or without lung metastases) and less than
5% present with metastases in other organs. There is no evidence of
invasion or metastasis in our case. Also, splitting calcification is seen
rarely [22]. However, our case was associated with Cushing's syndrome
which was a paraneoplastic syndrome. Thus, this is the first rare case
with ectopic ACTH syndrome caused by the peripheral primitive neu-
roectodermal tumor. Ectopic ACTH syndrome due to pPNET is ex-
tremely uncommon with no case being discussed in the literature.
4. Conclusion
pPNET associated with Cushing's syndrome is extremely rare. This is
the first report that didn't report cases in the literature. This report
intends to highlight that PNET should be suspected whenever a patient
presents with paraneoplastic Cushing's syndrome and may often be
confused with other tumors presented with the cushingoid syndrome.
Early diagnosis is important to ensure timely surgical resection fol-
lowed by appropriate chemotherapy and/or radiotherapy.
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